Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920180's FCF Margin % is ranked better than 71.46% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: -0.96
vs BJSE:920180: 9.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou And Science and Technology Development Co FCF Margin % Chart
Suzhou And Science and Technology Development Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou And Science and Technology Development Co FCF Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou And Science and Technology Development Co (BJSE:920180) has a FCF Margin % of -77.90% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Suzhou And Science and Technology Development Co and its competitors. According to the industry distribution chart, Suzhou And Science and Technology Development Co ranks #232 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 28.5%.
Is Suzhou And Science and Technology Development Co's FCF Margin % too high?
Suzhou And Science and Technology Development Co's current FCF Margin % is -77.90%. Based on the distribution chart, Suzhou And Science and Technology Development Co ranks #232 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Suzhou And Science and Technology Development Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou And Science and Technology Development Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Suzhou And Science and Technology Development Co ranks #232 out of 813 companies for FCF Margin %. This puts Suzhou And Science and Technology Development Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Suzhou And Science and Technology Development Co and its competitors. Suzhou And Science and Technology Development Co's current FCF Margin % is -77.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou And Science and Technology Development Co stock overvalued right now?
Suzhou And Science and Technology Development Co (BJSE:920180) has a current FCF Margin % of -77.90%. The current FCF Margin % is -77.90%. Suzhou And Science and Technology Development Co's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Suzhou And Science and Technology Development Co (BJSE:920180), the current FCF Margin % is -77.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou And Science and Technology Development Co Ltd is engaged in the research, development, manufacturing, and sale of medical devices, with a primary focus on orthopedic consumables. Its operations also include the distribution of these medical devices. The company's offerings include Spine products, Trauma products, Wound products, Joint products, Power products, and Transport medical products.
43GF Score
Get the complete analysis for BJSE:920180
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920180 has been successfully added to your 
